1Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: Epidemiology and etiology [J]. J Gastroenterol Hepatol, 2002; 17(10) : 1049
2Heron DE, Stein DE, Eschelman DJ, et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome[J].Am J Clin Oncol,2003;26(4):422
5Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary [J]. Ann Surg Oncol, 2000; 7(1): 55
6Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J]. Ann Surg, 2001; 234(4): 507
7Kawasaki S, Imamura H, Kobayashi A, etal. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization [J]. Ann Surg, 2003; 238(1):84
8Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate [J]. Ann Surg, 2003; 238(1): 73
9Nagino M, Nimura Y. Biliary drainage for hilar cholangiocarcinoma [J]. J Gastroenterol Surg, 2004; 8(Suppl): 12A
2Jie Yan~1 Li-Li Chen~2 Yi-Hui Luo~1 Ya-Fei Mao~1 Meng He~1 1 Department of Pathogenic Biology,Medical School of Zhejiang University,Hangzhou 310006,Zhejiang Province,China2 Department of Stomatology,The Second Affiliated Hospital,Medical School of Zhejiang University,Hangzhou 310009,Zhejiang Province,China.High frequencies of HGV and TTV infections in blood donors in Hangzhou[J].World Journal of Gastroenterology,2001,7(5):637-641. 被引量：11
3Zhi-Qiang Song~1 Fei Hao~1 Feng Min~2 Qiao-Yu Ma~2 Guo-Dong Liu~2 Department of Dermatology~1Department of Infectious Diseases~2,Southwest Hospital,Third Military Medical University,Chongqing 400038,China.Hepatitis C virus infection of human hepatoma cell line 7721 in vitro[J].World Journal of Gastroenterology,2001,7(5):685-689. 被引量：26
